Study Reveals Silica Nanoparticles Reduce Allergy Responses in Mouse Mast Cells
Silica nanoparticles dampen early allergy signals in mouse mast cells
Medical News
Image: Medical News
A study published in *Scientific Reports* shows that silica nanoparticles (SiO2) significantly dampen allergic reactions in mouse mast cells, while manganese-doped titanium dioxide nanoparticles (mTiO2) exhibit cytotoxic and pro-inflammatory effects. These findings suggest potential applications for nanotherapy in treating allergic diseases.
- 01Silica nanoparticles (SiO2) suppressed mast cell degranulation and activation markers in the presence of allergens.
- 02Manganese-doped titanium dioxide nanoparticles (mTiO2) caused significant cell death and inflammation in mast cells.
- 03The study utilized bone marrow-derived mast cells (BMMCs) from outbred SKH hairless mice to assess nanoparticle effects.
- 04SiO2 maintained over 90% cell viability after 24 hours, while mTiO2 reduced viability by over 30% after just one hour.
- 05Findings provide a mechanistic framework for developing nanotherapies targeting allergic conditions.
Advertisement
In-Article Ad
Research published in *Scientific Reports* investigated the effects of engineered nanoparticles on mast cell activation, focusing on silica (SiO2) and manganese-doped titanium dioxide (mTiO2) nanoparticles. The study found that SiO2 significantly inhibited antigen-induced mast cell activation, reducing degranulation and activation markers. In contrast, mTiO2 exhibited cytotoxic effects, decreasing cell viability and promoting inflammation. The study utilized bone marrow-derived mast cells (BMMCs) from SKH hairless mice, assessing the nanoparticles' impacts through various assays, including flow cytometry and cytokine measurements. Results indicated that SiO2 maintained over 90% viability after 24 hours, while mTiO2 caused a greater than 30% reduction in viability after one hour. These findings highlight the potential of SiO2 nanoparticles in modulating allergic responses and suggest avenues for future nanotherapy developments targeting allergic diseases.
Advertisement
In-Article Ad
The findings may lead to the development of new therapies for allergic diseases, which affect a significant portion of the population.
Advertisement
In-Article Ad
Reader Poll
Do you think nanoparticles could be a viable treatment option for allergies?
Connecting to poll...
Read the original article
Visit the source for the complete story.